Green fluorescent protein is a suitable reporter of tumor hypoxia despite an oxygen requirement for chromophore formation

被引:91
作者
Vordermark, D [1 ]
Shibata, T [1 ]
Brown, JM [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Radiat Oncol, Div Radiat & Canc Biol, Stanford, CA 94305 USA
来源
NEOPLASIA | 2001年 / 3卷 / 06期
关键词
green fluorescent protein; hypoxia; transfection; reoxygenation; fibrosarcoma;
D O I
10.1038/sj.neo.7900192
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The oxygen requirement for chromophore formation potentially limits the use of green fluorescent protein as a reporter under hypoxic conditions. In the light of this, the applicability of a hypoxia-responsive enhanced green fluorescent protein (EGFP)-based system to the measurement of tumor hypoxia was tested in human HT 1080 fibrosarcoma cells stably transfected with a destabilized EGFP vector containing the hypoxia-responsive 5HRE-hCMVmp promoter or, as a positive control, the strong constitutive CMV promoter. After various schedules of hypoxia and reoxygenation, EGFP fluorescence of live cells was assessed by flow cytometry, and protein levels were analyzed by Western blot. Fluorescence of CMV promoter positive control cells dropped to 38 +/-5% of aerobic levels after 12 hours at <0.02% oxygen, but was unaffected by higher oxygen concentrations. Following 12 hours at <0.02% oxygen, cells transfected with the hypoxia-responsive vector exhibited maximum fluorescence after 4 hours of subsequent reoxygenation, reaching 68 +/-2% of the levels in CMV promoter controls under aerobic conditions. With such reoxygenation, these cells exhibited a constant increase in fluorescence between 2% and <0.02% oxygen. EGFP chromophore formation is only affected by near-anoxic oxygen concentrations. The correlation of fluorescence and oxygen concentration is restored by a 4-hour reoxygenation period due to oxidation of pre-synthesized EGFP and a delayed increase in EGFP protein synthesis.
引用
收藏
页码:527 / 534
页数:8
相关论文
共 30 条
[1]   Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck [J].
Brizel, DM ;
Sibley, GS ;
Prosnitz, LR ;
Scher, RL ;
Dewhirst, MW .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 38 (02) :285-289
[2]   SR-4233 (TIRAPAZAMINE) - A NEW ANTICANCER DRUG EXPLOITING HYPOXIA IN SOLID TUMORS [J].
BROWN, JM .
BRITISH JOURNAL OF CANCER, 1993, 67 (06) :1163-1170
[3]   GREEN FLUORESCENT PROTEIN AS A MARKER FOR GENE-EXPRESSION [J].
CHALFIE, M ;
TU, Y ;
EUSKIRCHEN, G ;
WARD, WW ;
PRASHER, DC .
SCIENCE, 1994, 263 (5148) :802-805
[4]  
Evans H, 2000, JAVA REP, V5, P60
[5]   Oxygenation predicts radiation response and survival in patients with cervix cancer [J].
Fyles, AW ;
Milosevic, M ;
Wong, R ;
Kavanagh, MC ;
Pintilie, M ;
Sun, A ;
Chapman, W ;
Levin, W ;
Manchul, L ;
Keane, TJ ;
Hill, RP .
RADIOTHERAPY AND ONCOLOGY, 1998, 48 (02) :149-156
[6]   Diffusion limited hypoxia estimated by vascular image analysis: comparison with pimonidazole staining in human tumors [J].
Haustermans, K ;
Hofland, I ;
Van de Pavert, I ;
Geboes, K ;
Varia, M ;
Raleigh, J ;
Begg, AC .
RADIOTHERAPY AND ONCOLOGY, 2000, 55 (03) :325-333
[7]   WAVELENGTH MUTATIONS AND POSTTRANSLATIONAL AUTOXIDATION OF GREEN FLUORESCENT PROTEIN [J].
HEIM, R ;
PRASHER, DC ;
TSIEN, RY .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (26) :12501-12504
[8]   IMPROVED GREEN FLUORESCENCE [J].
HEIM, R ;
CUBITT, AB ;
TSIEN, RY .
NATURE, 1995, 373 (6516) :663-664
[9]  
Hockel M, 1996, CANCER RES, V56, P4509
[10]   FLOW CYTOMETRIC EVALUATION OF HYPOXIC CELLS IN SOLID EXPERIMENTAL-TUMORS USING FLUORESCENCE IMMUNODETECTION [J].
HODGKISS, RJ ;
JONES, G ;
LONG, A ;
PARRICK, J ;
SMITH, KA ;
STRATFORD, MRL ;
WILSON, GD .
BRITISH JOURNAL OF CANCER, 1991, 63 (01) :119-125